Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and Metformin
Clinical trial NCT05504239 · COMPLETED
Trial details
- NCT number
- NCT05504239
- Sponsor
- Handok Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-27
- Primary completion
- 2024-04-23
- Enrollment
- 235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.